Ticker Details
RenovoRx, Inc.
IPO Date:	August 26, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$44.08M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 4.64%
Avg Daily Range (30 D):	$0.04 | 4.00%
Avg Daily Range (90 D):	$0.04 | 3.78%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.35M
Avg Daily Volume (90 D):	.24M

Trade Size
Avg Trade Size (Sh.):	181
Avg Trade Size (Sh.) (30 D):	341
Avg Trade Size (Sh.) (90 D):	343

Institutional Trades
Total Institutional Trades:	8
Avg Institutional Trade:	$1.13M
Avg Institutional Trade (30 D):	$M
Avg Institutional Trade (90 D):	$M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	K

News

Apr 1, 2026 @ 6:20 PM RenovoRx Named to Fast Company’s Annual Lis... Source: Renovorx, Inc.

Jun 26, 2024 @ 12:30 PM University of Nebraska Medical Center Launches Pat... Source: RenovoRx, Inc.

Jun 10, 2024 @ 12:30 PM RenovoRx Appoints Ryan Witt as Senior Vice Preside... Source: RenovoRx, Inc.

Jan 2, 2024 @ 6:35 PM Why Longboard Pharmaceuticals Shares Are Trading H... Source: Avi Kapoor

Dec 28, 2023 @ 6:07 PM Why DouYu International Shares Are Trading Higher ... Source: Avi Kapoor

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.32	$-.08	$-.32
Diluted EPS	$-.32	$-.08	$-.32
Revenue	$1.12M	$.54M	$1.12M
Gross Profit	$.8M		$.8M
Net Income / Loss	$-11.17M	$-2.94M	$-11.17M
Operating Income / Loss	$-12.51M	$-3.52M	$-12.51M
Cost of Revenue	$.33M		$.33M
Net Cash Flow	$-.13M	$-.13M	$-.13M
PE Ratio